Trends in Prevalence, Treatment, and Relationship of Metabolic Syndrome and Individual Components by Race/Ethnicity, 1999-2018
MetS prevalence has increased over 2 decades. Persistent racial/ethnic disparities exist in antihypertensive, antihyperglycemic, and lipid-lowering medication use. Across all racial/ethnic subgroups, large opportunities remain for improving treatment strategies among individuals with medication indications.
Authors
- Jeph Herrin (ORCID: https://orcid.org/0000-0002-3671-3622)
- Xumin Li (ORCID: https://orcid.org/0000-0002-0547-7049)
- Erica S. Spatz (ORCID: https://orcid.org/0000-0002-1557-7713)
- César Caraballo (ORCID: https://orcid.org/0000-0002-4557-9437)
- Yuntian Liu (ORCID: https://orcid.org/0000-0001-6571-6112)
- Daisy Massey (ORCID: https://orcid.org/0000-0002-9922-7808)
- Shiwani Mahajan (ORCID: https://orcid.org/0000-0002-5617-489X)
- Yuan Lu (ORCID: https://orcid.org/0000-0001-5264-2169)
- Harlan M. Krumholz (ORCID: https://orcid.org/0000-0003-2046-127X)
Institutions
- Yale New Haven Hospital (US)
- Yale University (US)
- Yale New Haven Health System (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-05-14
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101785
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00